Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinomaResearch in context
Background: In the clinic, how to stratify renal cell carcinoma (RCC) patients with different risks and to accurately predict their prognostic outcome remains a crucial issue. In this study, we assessed the expression and prognostic value of gankyrin in RCC patients. Methods: The expression of ganky...
Main Authors: | Chao Wang, Yan Li, Chuan-min Chu, Xiang-min Zhang, Jie Ma, Hai Huang, Yu-ning Wang, Tian-yu Hong, Jing Zhang, Xiu-wu Pan, Jing-cun Zheng, Ning Jiang, Chuan-yi Hu, Xiaojing Ma, Ying-hao Sun, Xin-gang Cui |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396418305826 |
Similar Items
-
Pathway-based biomarker identification with crosstalk analysis for robust prognosis prediction in hepatocellular carcinomaResearch in context
by: Botao Fa, et al.
Published: (2019-06-01) -
Gankyrin as Potential Biomarker for Colorectal Cancer With Occult Liver Metastases
by: Chengxing Wang, et al.
Published: (2021-07-01) -
Studies on gankyrin
by: Elsafty, RoÌisiÌn
Published: (2002) -
Gankyrin gene deletion followed by proteomic analysis: insight into the roles of Gankyrin in Tumorigenesis and Metastasis
by: Luo Xue, et al.
Published: (2012-08-01) -
Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinomaResearch in context
by: Yang Cheng, et al.
Published: (2019-02-01)